SecutriL-VT is a combination of sacubitril 49mg a neprilysin inhibitor and valsartan 51mg an angiotensin receptor blocker, indicated to reduce the risk of cardioascular death and hospitalization for heart failure in patients with chronic heart failure and reduced ejection fraction.
KES 1,582.00
Delivery within 4 hours on all orders placed between 8:00 AM & 8:00 PM
Facebook
WhatsApp
Twitter